Supporting these results, nqo1−/− mice exhibit higher triglyceride levels than their normal counterparts [32], whereas pharmacological activation of nqo1 in mice models of MetS results in lower triglyceride levels [33]. The gene discussed is NQO1; the disease is metabolic syndrome.